The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
In April 1975, the mass vaccination of newborns against tuberculosis was replaced by selective vaccination of groups at risk. BCG coverage fell from more than 95% before 1974 to 1.8% between 1975 and 1982 and thereafter reached an average of 13.7% up to 1989. The cumulative incidence of tuberculosis before 5 years of age was estimated among children born in Sweden during periods of high, low and moderate increasing BCG coverage. The incidence figures per 100,000 children was 0.8, 3.9 and 2.9, respectively, for children born to Swedish parents and 2.6, 39.4 and 13.2, respectively, for those born to foreign parents. The observed incidence of tuberculosis among non-BCG vaccinated children born to Swedish parents was within the expected limits given by a prognostic model based on the natural change of the risk of infection. The effectiveness of the selective BCG vaccination programme, which was intensified after 1981 for the second generation of immigrants, was estimated to 0.82 (95% confidence interval 0.38, 0.95) assuming that there was no change of the risk of infection for children born to foreign parents over the period studied. From April 1975 to December 1989, tuberculosis was notified in 85 children born in Sweden during the same period, 7 of them were BCG vaccinated and 78 non-vaccinated, 45 were symptomatic, 3 of them with disseminated tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In April 1975, it stopped its newborn BCG vaccination program, leading to a dramatic drop in the BCG vaccination rate from 92% to 2% for cohorts born just before and just after the change [16].”
From Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden (2021) · cites this paper as [16]
Citations
Cites
Geigy, J. R. (1981) · Medical Entomology and Zoology · Cited by 1,221
OSTEITIS AND OTHER COMPLICATIONS CAUSED BY GENERALIZED BCG‐ITIS
Böttiger, M., Romanus, V., de Verdier, C., & Boman, G. (1982) · Acta Paediatrica · doi:10.1111/j.1651-2227.1982.tb09454.x · Cited by 71
Self-citationThe association of the risk of tuberculous infection with age.
Sutherland, I., & Fayers, P. M. (1975) · PubMed · Cited by 49
Childhood tuberculosis in Sweden
Romanus, V. (1983) · Tubercle · doi:10.1016/0041-3879(83)90034-x · Cited by 44
Self-citationVACCINE EVALUATION BY CASE-CONTROL OR PROSPECTIVE STUDIES
Comstock, G. W. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115490 · Cited by 41
Romanus, V. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198703000-00014 · Cited by 36
Self-citationReappearance of Childhood Tuberculous Meningitis in Sweden
Kindmark, C.-O., Friman, G., & Nõu, E. (1982) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1982.14.issue-2.16 · Cited by 27
Okasha, M. (2001) · BMJ · doi:10.1136/sbmj.0108277 · Cited by 26
Incidence of tuberculosis among Scandinavian immigrants in Canada.
Enarson, D. A., Sjögren, I., & Grzybowski, S. (1980) · PubMed · Cited by 23
Perinatal Transmission of Tuberculosis: Meningitis in Mother, Disseminated Disease in Child
Petrini, B., Gentz, J., Winbladh, B., Sköldenberg, B., & Westin, B. (1983) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1983.15.issue-4.12 · Cited by 14
Research works printed but not linked: 17
- Böttiger, 1986, Tuberkuloskontrollen i Sverige — ett förslag (Tuberculosis control in Sweden — a proposal), Läkartidningen, 83, 1593
- Sjögren, 1984, Practical consequences of estimating the risk of tuberculous infection in the policy making in Sweden, Bull Int Union Tuberc, 59, 132
- National Board of Health and Welfare, Stockholm, 1972, Statute-Book MF, 29
- National Board of Health and Welfare, Stockholm, 1976, Statute-Book SOS FS (M), 37
- National Board of Health and Welfare, Stockholm, 1981, Directions and general advice concerning tuberculin-testing and BCG-vaccination, Statute-Book SOS FS (M), 46
- National Board of Health and Welfare, Stockholm, 1983, Announcement no. 23
- 1982, vol. 2, 221
- 1982, vol. 2, 224
- Sutherland, 1975, Tuberculosis Surveillance Research Unit Report No. 3, 72
- Rouillon, 1976, BCG-vaccination and epidemiological situation, Adv Tuberc Res, 19, 64
- 1959, Tuberculosis Register
- Elgefors, 1983, Tuberkulös meningit-fallbeskrivning och behandlingsschema. Tuberculous meningitis — case report and treatment, Läkartidningen, 80, 2027
- Tala, 1990, Five years' trend of tuberculosis in Europe — IUATLD Europe Region and WHO Study, Am Rev Respir Dis, 141
- Tala, 1990, Tuberkulos i Norden (Tuberculosis in the Nordic countries) (in Swedish, abstract in English), Nord Med, 105, 320
- 1980, Einschränkung immunprophylaktisher Massnahmen gegen die Kinder-Tuberkulose?, Sozialpädiatrie, 2, 285
- Landmann, 1986, Zum aktuellen Stellenwert der Tuberkuloseschutzimpfung, Z Arztl Fortbild (Jena), 80, 673
- Trnka, 1990, Project on discontinuation of BCG-vaccination in newborn in Czechoslovakia, Bull Int Union Tuberc Lung Dis, 65, 36
Cited by
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Early BCG vaccination and development of atopy
Alm, J. S., Lilja, G., Pershagen, G., & Scheynius, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02207-1 · Cited by 254
Romanus, V., Hallander, H. O., Wåhlén, P., Olinder-Nielsen, A. M., Magnusson, P. H. W., & Juhlin, I. (1995) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(05)80028-0 · Cited by 140
Self-citationTuberculosis control in Europe and international migration
Rieder, H., Jp, Z., Raviglione, M. C., St, K., & Migliori, G. B. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07081545 · Cited by 140
(1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90003-5 · Cited by 102
New Vaccines for the Prevention of Tuberculosis
von Reyn, C. F., & Vuola, J. M. (2002) · Clinical Infectious Diseases · doi:10.1086/341901 · Cited by 70
Bacillus Calmette-Guérin Revaccination Questionable with Low Tuberculosis Incidence
Tala-Heikkilä, M., Tuominen, J., & Tala, E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9706037 · Cited by 68
“This increase could be demonstrated in Sweden within 4 yr (3, 7 ). The same phenomenon was seen in Czechoslovakia (9).”
BackgroundResultInfluentialAngelidou, A., Diray‐Arce, J., Conti, M. G., Smolen, K. K., van Haren, S. D., Dowling, D. J., Husson, R. N., & Levy, O. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00332 · Cited by 75
Bacille Calmette-Guerin Vaccines: A Rough Guide
Fine, P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.11 · Cited by 66
Hart, C. A., Beeching, N. J., & Duerden, B. I. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-44-1-1 · Cited by 59
Romanus, V., Fasth, A. L., Tordai, P., & Wiholm, B. E. (1993) · Acta Paediatrica · doi:10.1111/j.1651-2227.1993.tb12808.x · Cited by 58
Self-citationSix years' experience with the discontinuation of BCG vaccination
Trnka, L., Dănkovã, D., & Svandova, E. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90006-j · Cited by 57
BCG Vaccination and Risk of Atopy
rause, T. G., Hviid, A., Koch, A., Friborg, J., Hjuler, T., Wohlfahrt, J., Olsen, O. R., Kristensen, B., & Melbye, M. (2003) · JAMA · doi:10.1001/jama.289.8.1012 · Cited by 55
The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination
Dahlquist, G., & Gothefors, L. (1995) · Diabetologia · doi:10.1007/bf03035306 · Cited by 52
Mycobacterial species causing pulmonary tuberculosis At the korle bu teaching hospital, Accra,
Addo, K. K., Owusu-Darko, K., Yeboah‐Manu, D., Caulley, P., Minamikawa, M., Bonsu, F. A., Leinhardt, C., Akpedonu, P., & Ofori‐Adjei, D. (2010) · Ghana Medical Journal · doi:10.4314/gmj.v41i2.55293 · Cited by 44
de Chaisemartin, C., & de Chaisemartin, L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1223 · Cited by 43
“Based on nationwide reports on the vaccination status of children below 7 sent to the National Bacteriological Laboratory in 1981, 92% of children born in 1974 got vaccinated, against 26% of those born in 1975, and less than 2% of those born between 1976 and 1980[16].”
BackgroundInfluentialEconomic evaluation of universal BCG vaccination of Japanese infants
Rahman, M. M., Sekimoto, M., Takamatsu, I., Hira, K., Shimbo, T., 豊島, 協., & Fukui, T. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.2.380 · Cited by 29
Cohn, D. L. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40139-9 · Cited by 27
Estimation de l’impact épidémiologique de différentes options de vaccination BCG en France
Lévy-Bruhl, D. (2005) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(05)84727-3 · Cited by 26
Guthmann, J., Antoine, D., Fonteneau, L., Che, D., & Lévy-Bruhl, D. (2011) · Eurosurveillance · doi:10.2807/ese.16.12.19824-en · Cited by 26
Tuberculosis into the next century
Beeching, N. J. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)80012-0 · Cited by 26
Selective BCG vaccination in a country with low incidence of tuberculosis
Romanus, V. (2006) · Eurosurveillance · doi:10.2807/esm.11.03.00606-en · Cited by 26
Self-citationGorak‐Stolinska, P., Weir, R. E., Floyd, S., Lalor, M. K., Stenson, S., Branson, K. R., Blitz, R., Luke, S., Nazareth, B., Ben‐Smith, A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.037 · Cited by 25
Manissero, D., Lopalco, P. L., Lévy-Bruhl, D., Atti, M. L. C. D., & Giesecke, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.038 · Cited by 27
Addo, K. K., Owusu-Darko, K., Yeboah‐Manu, D., Caulley, P., Minami, M., Bonsu, F. A., Leinhardt, C., Akpedonu, P., Ofori‐Adjei, D., & African, W. (2007) · Cited by 23
Six years' experience with the discontinuation of BCG vaccination
Trnka, L., Dănkovã, D., & Svandova, E. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90056-4 · Cited by 23
de March-Ayuela, P. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90115-5 · Cited by 23
BCG in Finland: changing from a universal to a selected programme
Salo, E. (2006) · Eurosurveillance · doi:10.2807/esm.11.03.00607-en · Cited by 21
Early Vaccinations Are Not Risk Factors for Celiac Disease
Myléus, A., Stenlund, H. C., Hernell, O., Gothefors, L., Hammarström, M., Persson, L. Å., & Ivarsson, A. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2806 · Cited by 21
ORIGINAL ARTICLE: Vaccination of children – a systematic review
Örtqvist, A. K., Blennow, M., Carlsson, R. M., La, H., Lindberg, A., LINDQVIST, L., Magnusson, M., Nilsson, L. J., Norlund, A., Nyrén, O., et al. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.01823.x · Cited by 32
Barriers to implementation of the new targeted BCG vaccination in France: A cross sectional study
Rossignol, L., Guthmann, J., Kernéis, S., Aubin-Auger, I., Lasserre, A., Chauvin, P., Pelat, C., Hanslik, T., Lévy-Bruhl, D., & Blanchon, T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.020 · Cited by 23
Cohn, D. L. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199706000-00010 · Cited by 16
Protective effect of neonatal BCG vaccines against tuberculous meningitis
Puvačić, S., Dizdarević, J., Šantić, Ž., & Mulaomerović, M. (2004) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2004.3460 · Cited by 15
Chlamydial infection of the respiratory tract.
Wreghitt, T. G. (1993) · PubMed · Cited by 14
Feiring, B., Laake, I., Molden, T., Håberg, S. E., Nøkleby, H., Seterelv, S. S., Magnus, P. M., & Trogstad, L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.060 · Cited by 13
Bui, T. V., Lévy-Bruhl, D., Che, D., Antoine, D., Jarlier, V., & Robert, J. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.11.21064 · Cited by 12
Klein, B. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.066 · Cited by 14
BCG Vaccination and Tuberculosis in Japan.
Rahman, M. M., Takahashi, O., Goto, M., & Fukui, T. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.127 · Cited by 12
Parache, C., Carcopino, X., Gossot, S., Retornaz, K., Uters, M., Mancini, J., Garnier, J. M., & Minodier, P. (2010) · Archives de Pédiatrie · doi:10.1016/j.arcped.2010.01.014 · Cited by 11
Mycobacterium bovisBCG and New Vaccines for the Prevention of Tuberculosis
Lahey, T., & von Reyn, C. F. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0003-2016 · Cited by 11
Evaluating the neonatal BCG vaccination programme in Ireland
Usher, C., Adams, R., Schmitz, S., Kieran, J., O’Flanagan, D., O’Donnell, J., Connolly, K., Corcoran, B., BUTLER, K. M., Barry, M. G., et al. (2016) · Archives of Public Health · doi:10.1186/s13690-016-0141-0 · Cited by 9
Bennet, R., & Eriksson, M. (2016) · Acta Paediatrica · doi:10.1111/apa.13629 · Cited by 10
BCG vaccine: information and recommendations for use in Australia
National Tuberculosis Advisory Committee (2006) · Communicable Diseases Intelligence · doi:10.33321/cdi.2006.30.5 · Cited by 10
La tuberculose en France: Comment arrêter l'épidémie actuelle?
Bègué, P., Carbonnelle, B., Cartier, F., Chrétien, J., Delaval, P., Dellamonica, P., Desenclos, J. C., Durieux, P., Lagrange, P. H., Léophonte, P., et al. (1995) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(05)80611-0 · Cited by 10
Nguipdop‐Djomo, P., Mangtani, P., Pedrazzoli, D., Rodrigues, L. C., & Abubakar, I. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203931 · Cited by 9
“In Sweden, uptake among eligible infants dropped from over 95% to 2% when universal neonatal BCG was replaced by a targeted programme in 1975[1].”
BackgroundSmith, K. C., Orme, I. M., & Starke, J. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00040-9 · Cited by 13
listed, N. A. (2013) · Communicable Diseases Intelligence · doi:10.33321/cdi.2013.37.7 · Cited by 9
Vaudry, W. (2003) · Paediatrics & Child Health · doi:10.1093/pch/8.3.141 · Cited by 9
Hanekom, W. A., Hawn, T. R., & Ginsberg, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00060-2 · Cited by 8
Guthmann, J., Chauvin, P., Strat, Y. L., Soler, M., Fonteneau, L., & Lévy-Bruhl, D. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.059 · Cited by 9
Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination
Kobayashi, S., Yoshiyama, T., Uchimura, K., Hamaguchi, Y., & Kato, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95294-y · Cited by 7
Vaccin BCG et place de l'intradermoréaction en 2006
Billy, C., & Lévy-Bruhl, D. (2006) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2006.09.023 · Cited by 7
Assessment of the need for universal BCG vaccination of children in Taipei
Wang, P.-D. (2008) · Public Health · doi:10.1016/j.puhe.2008.10.002 · Cited by 6
Teljeur, C., Moran, P. S., Harrington, P., BUTLER, K. M., Corcoran, B., O’Donnell, J., Usher, C., O’Flanagan, D., Connolly, K., & Ryan, M. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001891 · Cited by 6
BCG—mass or selective vaccination?
Watson, J. M. (1995) · Journal of Hospital Infection · doi:10.1016/0195-6701(95)90056-x · Cited by 6
Koch‐Weser, D. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1641 · Cited by 6
Kontturi, A., Kekomäki, S., Soini, H., Ollgren, J. P., & Salo, E. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.11.1900711 · Cited by 5
Jackson, S., Kabir, Z., & Comiskey, C. M. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.02.061 · Cited by 4
Pros and Cons of BCG Vaccination in Countries with Low Incidence of Tuberculosis
Tala, E., & Tala-Heikkilä, M. (1994) · Infection Control and Hospital Epidemiology · doi:10.1086/646958 · Cited by 4
Abbott, S., Christensen, H., Welton, N. J., & Brooks‐Pollock, E. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.49.1900220 · Cited by 4
Lévy-Bruhl, D. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74891-6 · Cited by 3
Pros and Cons of BCG Vaccination in Countries with Low Incidence of Tuberculosis
Tala, E., & Tala-Heikkilä, M. (1994) · Infection Control and Hospital Epidemiology · doi:10.2307/30148502 · Cited by 3
Infant tuberculosis in Austria—Trend reversal since 1990?
Makristathis, A., Stauffer, F., Klein, J. P., Rotter, M. L., Wewalka, G., & Hirschl, A. M. (1998) · Infection · doi:10.1007/bf02768752 · Cited by 3
Quelle place pour le BCG en France ?
Lévy-Bruhl, D. (2002) · Archives de Pédiatrie · doi:10.1016/s0929-693x(01)00685-6 · Cited by 3
Towards explaining the Swedish epidemic of celiac disease : an epidemiological approach
Myléus, A. (2012) · DiVA at Umeå University (Umeå University) · Cited by 8
Mycobacterium bovis BCG and New Vaccines against Tuberculosis
Lahey, T., & von Reyn, C. F. (2014) · Wiley eBooks · doi:10.1128/9781555817138.ch10 · Cited by 3
Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis
Lahey, T., & von Reyn, C. F. (2017) · ASM Press eBooks · doi:10.1128/9781555819866.ch11 · Cited by 3
Bekkering, S., Singh, K., Lü, H., Limawan, A. P., Nold‐Petry, C. A., Wallace, M. J., Curtis, N. C., Pepe, S., Cheung, M. M. H., Burgner, D. P., et al. (2022) · Biology · doi:10.3390/biology11101511 · Cited by 2
“, MIS-BAIR [26]) provide an opportunity for these investigations, as do observational population-based studies in countries (such as Sweden) where universal newborn BCG vaccination was discontinued at a single time point [27].”
BackgroundBCG : la poursuite de la vaccination des enfants à risque est indispensable
Gaudelus, J. (2008) · Archives de Pédiatrie · doi:10.1016/s0929-693x(08)71873-6 · Cited by 1
Bonamonte, D., Filoni, A., & Angelini, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-48538-6_4 · Cited by 1
Smith, K. C., Orme, I. M., & Starke, J. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50037-4 · Cited by 2
Evidence and guidance on vaccine safety and effectiveness in subpopulations
Mak, T. K. (2011) · edoc (University of Basel) · doi:10.5451/unibas-005754014 · Cited by 1
BCG : il est essentiel de continuer à vacciner les enfants à risque
Gaudelus, J. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2008.06.016 · Cited by 1
BCG et tests tuberculiniques : évolutions de la politique vaccinale française
Lévy-Bruhl, D., Barrault, Y., Decludt, B., & Schwoebel, V. (2003) · Archives de Pédiatrie · doi:10.1016/s0929-693x(03)00166-0 · Cited by 1
Rey, M. J. (1995) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(05)80607-9 · Cited by 1
Guerin, N. (1995) · Pediatric Pulmonology · doi:10.1002/ppul.1950191111 · Cited by 1
Lévy-Bruhl, D., Barrault, Y., Decludt, B., & Schwoebel, V. (2003) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(03)00063-5 · Cited by 1
Lévy-Bruhl, D. (2006) · La Presse Médicale · doi:10.1016/j.lpm.2006.09.016 · Cited by 1
Igari, H., Onozaki, I., Sunami, Y., Suzuki, K., Shimura, A., & Nagao, K. (1998) · PubMed
BCG : il est essentiel de continuer à vacciner les enfants à risque
Gaudelus, J. (2009) · Journal de Pédiatrie et de Puériculture · doi:10.1016/j.jpp.2009.05.001
Abbott, S., Christensen, H., & Brooks‐Pollock, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/624916
The BCG Vaccine Does not Protect against COVID-19. Evidence from a Natural Experiment in Sweden.Preprint
de Chaisemartin, C. (2020) · SSRN Electronic Journal · doi:10.48550/arxiv.2006.05504
Abbott, S., Christensen, H., & Brooks‐Pollock, E. (2022) · BMJ Open · doi:10.1136/bmjopen-2019-031573
Lévy-Bruhl, D., Denis, F., & Gicquel, B. (2006) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(06)40086-7
Lévy-Bruhl, D., Denis, F., & Gicquel, B. (2006) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(06)70386-5
Metadata
- Authors
- Romanus, V., Svensson, Å., & Hallander, H. O.
- Corresponding author
- Romanus, V.
- ORCID
- Svensson, Å.
- Venue
- Tubercle and Lung Disease
- Publisher
- Elsevier BV
- Published
- 1992-06
- Volume
- 73
- Issue
- 3
- Pages
- 150-161
- ISSN
- 0962-8479 (ISSN-L)
- OpenAlex
- W2056993217
- Cited by
- 86
- References
- 16
- Citations by year
- 2024: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Tubercle and Lung Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- International Union Against Tuberculosis and Lung Disease
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- tuberculosis, BCG vaccination, vaccination coverage, selective vaccination, mass vaccination, immigrant children, foreign-born children, vaccination effectiveness, Swedish immigrants, tuberculosis control policy, disseminated tuberculosis
- MeSH terms
- Adolescent, Africa, Asia, BCG Vaccine, Child, Child, Preschool, Finland, Forecasting, Humans, Infant, Infant, Newborn, Latin America, Risk Factors, Sweden, Tuberculosis, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.